SPI-2012 vs Pegfilgrastim in the Management of Neutropenia in Participants With Breast Cancer With Docetaxel and Cyclophosphamide (ADVANCE)
Clinical trial NCT02643420 · COMPLETED
Trial details
- NCT number
- NCT02643420
- Sponsor
- Spectrum Pharmaceuticals, Inc
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-19
- Primary completion
- 2018-01-24
- Enrollment
- 406
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.